Kinome profiling in pediatric brain tumors as a new approach for target discovery

Arend H Sikkema1, Sander H Diks, Wilfred F A den Dunnen

  • 1Department of Pediatric Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Cancer Research
|July 2, 2009
PubMed

Insights

New kinome profiling identifies Src family kinases as key drivers in pediatric brain tumors. This high-throughput method rapidly discovers potential therapeutic targets for various cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Pediatric brain tumor growth is driven by complex protein kinase signaling networks.
  • Identifying novel therapeutic targets is challenging without understanding aberrant cell signaling.
  • Kinome profiling offers a potential solution for target discovery in malignancies.

Purpose of the Study:

  • To introduce and validate kinome profiling using flow-through peptide microarrays for pediatric brain tumor target discovery.
  • To identify specific tyrosine kinase activity profiles in pediatric brain tumors.
  • To assess the therapeutic potential of targeting identified kinases.

Main Methods:

  • Utilized the PamChip kinome profiling system on 29 pediatric brain tumors.
  • Analyzed tyrosine kinase activity profiles and phosphorylation consensus sequences.
  • Confirmed Src activity using Phos-Tag SDS-PAGE.
  • Tested Src family kinase inhibitors (PP1, dasatinib) on pediatric brain tumor cell lines.

Main Results:

  • Comprehensive tyrosine kinase activity profiles were generated for pediatric brain tumors.
  • Previously known kinase activities (EGFR, c-Met, VEGFR) were confirmed.
  • Significantly elevated phosphorylation of Src family kinase substrates was observed.
  • Src family kinase inhibitors demonstrated significant tumor cell death in pediatric brain tumor cell lines.

Conclusions:

  • Kinome profiling is a novel, high-throughput technique for generating clinically relevant kinase activity profiles.
  • This approach successfully identified Src family kinases as critical in pediatric brain tumors.
  • The findings highlight a new strategy for rapid identification of therapeutic targets in diverse human malignancies.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...